Organ Biological Age
The concept that individual organs — the heart, brain, liver, or kidneys — can age at markedly different rates within the same person, measurable through analysis of tissue-specific plasma proteins rather than a single, averaged 'biological age' score.
Number of studies
2
Safety
High
Time to effects
Not applicable — this is a measurement biomarker, not an intervention with a measurable time course of effect.
Who it's for
Table of contents
TL;DR
The concept that individual organs — the heart, brain, liver, or kidneys — can age at markedly different rates within the same person, measurable through analysis of tissue-specific plasma proteins rather than a single, averaged 'biological age' score.
- →Can reveal that a single person may have accelerated aging in one specific organ while the rest age at a normal rate — information unavailable from a single, averaged 'biological age' score
- →In large cohort studies, accelerated aging of a specific organ was linked to elevated risk of diseases affecting that organ, independent of traditional risk factors
- →Results were partly replicated in an independent cohort (Whitehall II), which increases confidence in the concept compared with many other new aging biomarkers
| Definition | Estimated biological age of a specific organ based on plasma proteins originating from that organ |
|---|---|
| Research level | Moderate — large cohort studies with partial validation in independent populations |
| Measurement method | Plasma proteomics (e.g., SomaScan technology) analyzed with machine learning models for roughly 11 major organs |
| Key study | Oh et al. 2023, Nature — 11 organ clocks, more than 5,600 people across 5 cohorts |
| Key finding | About 20% of the population shows markedly accelerated aging in one organ, and 1.7% in multiple organs at once |
| Clinical link | Accelerated heart aging was linked to roughly a 250% higher risk of heart failure |
| Status | Research tool, replicated in independent cohorts (including Whitehall II), not clinically standardized |
Understand
Overview
The concept of organ biological age holds that aging doesn't proceed uniformly across the whole body — individual organs such as the heart, brain, liver, kidneys, or lungs can age at noticeably different rates within the same person. Instead of one averaged 'biological age' score for the whole body, researchers build separate models ('organ clocks') for each organ, based on the concentrations of blood plasma proteins strongly enriched in that particular organ.
A landmark study in this field was published by Tony Wyss-Coray's team in 2023 in the journal Nature, covering more than 5,600 people across five independent cohorts and 11 major organs. It found that roughly 20% of the study population showed markedly accelerated aging in at least one specific organ, and 1.7% showed accelerated aging across multiple organs at once ('multi-organ agers'). Accelerated aging of a given organ was linked in this study to elevated risk of diseases affecting that same organ — for example, accelerated heart aging was linked to roughly a 250% higher risk of heart failure, and accelerated aging of the brain and blood vessels was linked to faster progression of changes characteristic of Alzheimer's disease. Independent validation of this concept in the UK Whitehall II cohort (a 20-year follow-up) confirmed the link between accelerated aging of individual organs and the risk of organ-specific diseases.
Who can realistically benefit from this? People interested in whether a single, averaged 'biological age' score adequately captures the complexity of how the body ages, as well as researchers and clinicians interested in early prediction of disease risk for specific organs. It's worth remembering, though, that despite solid scientific validation, organ clocks remain a research tool built on advanced proteomics (e.g., SomaScan technology) — they are not yet available as a routine, standardized clinical test.
Mechanism of action
The method relies on so-called organ-enriched proteins — molecules present in blood plasma whose gene expression is disproportionately high in a specific organ (determined from gene expression databases such as GTEx). Researchers measure the concentrations of thousands of plasma proteins simultaneously using large-scale proteomic technologies (e.g., the aptamer-based SomaScan platform), then train a separate machine learning model for each organ, comparing a given person's actual level of that organ's enriched proteins against the level expected for their chronological age. The difference between these values, called the 'organ age gap,' is conceptually analogous to epigenetic age acceleration, but is based on proteomic data rather than DNA methylation, and is calculated separately for each of the roughly 11 organs analyzed.
A high correlation of results across a person's different organs suggests a shared, systemic aging process, while a low correlation — a situation where one organ ages markedly faster than the others — points to a more idiosyncratic, organ-specific process. It's this second scenario that is most clinically interesting, since a single, averaged whole-body biological age score would mask this kind of localized accelerated aging.
Identifying organ-specific proteins
Researchers select plasma proteins strongly enriched in a specific organ based on gene expression data from databases such as GTEx.
Building the organ age model
A machine learning algorithm compares a given person's levels of these proteins against the level expected for their chronological age, producing a separate score for each organ.
Calculating the organ age gap
The difference between predicted and chronological age for a given organ indicates whether that organ is aging faster, slower, or in line with the rest of the body.
Evidence: moderate — based on 2 studies in this database.
Benefits
Common myths
MythOrgan biological age is already an available, standardized clinical test.
FactThe method relies on advanced, large-scale proteomics and remains a research tool — it is not yet available as a routine, standardized test in clinical practice.
MythIf the score for one organ shows a 'young' age, the whole body must be aging slowly.
FactThis discrepancy between organs is exactly the point of the concept — studies show that one organ can age faster than the others in the same person, something a single averaged biological age score would mask.
Check your profile
Not sure which supplements actually make sense for you?
Answer a few short questions about your lifestyle, diet, sleep, and goals. VitMode will build your profile and show supplements worth considering — with reasoning and evidence strength.
Recommendations take your answers and the strength of the scientific evidence into account. A supplement's popularity has no bearing on whether it gets recommended.
Practice
Frequently asked questions
Overall biological age (e.g., from epigenetic clocks) gives a single averaged score for the whole body, while organ biological age breaks that assessment down into separate scores per organ, revealing whether any one of them is aging faster than the rest of the body.
The landmark 2023 study assessed 11 major organs, including the heart, brain, liver, kidneys, lungs, and immune system, based on the concentrations of plasma proteins enriched in each organ.
Not as a standard clinical test — the method relies on advanced, large-scale proteomics currently available mainly in a research context rather than in routine diagnostics.
This is a term from the Oh et al. study describing people (about 1.7% of the study population) whose accelerated aging affected multiple organs simultaneously rather than just one — which was linked to higher overall morbidity and mortality risk.
What to combine with
Good combinations
Biological Age Clocks — Organ clocks complement general biological age clocks by breaking a single score down into organ-specific components
Safety
Side effects & contraindications
Possible side effects
Contraindications
No significant contraindications at typical doses.
Is it worth taking?
Who it's for
- People interested in whether a single 'biological age' score adequately captures the complexity of how the body ages
- Researchers and clinicians interested in early prediction of disease risk for specific organs
Not for
- No significant contraindications at typical doses.
Evidence
Worth knowing
In an analysis of more than 5,600 people, about 20% of the population showed markedly accelerated aging in one specific organ, and 1.7% were so-called 'multi-organ agers' — people with accelerated aging across multiple organs at once.
Accelerated aging of the brain and blood vessels in the Oh et al. study was linked to faster progression of changes characteristic of Alzheimer's disease.
Studies
Organ aging signatures in the plasma proteome track health and disease
Moderate evidenceOh HSH, Rutledge J, Nachun D, et al. · Nature · 2023
A landmark study building 11 organ-aging clocks from plasma proteomics in more than 5,600 people across 5 cohorts; showed that accelerated aging of a specific organ increases the risk of diseases affecting that organ and overall mortality.
View studyProteomic organ-specific ageing signatures and 20-year risk of age-related diseases: the Whitehall II observational cohort study
Moderate evidenceKivimäki M, Frank P, Pentti J, et al. · The Lancet Digital Health · 2025
Independent validation of the organ-clock concept in the UK Whitehall II cohort with 20 years of follow-up, confirming the link between accelerated aging of individual organs and elevated risk of organ-specific diseases.
View studySources & bibliography
Citations are illustrative for this demo version and require full bibliographic verification by the editorial team before production publication.
Compare with similar entries
About the authors of this entry
Author
dr Anna KowalczykEditor-in-Chief, Molecular Biology
Anna studied molecular biology at the University of Warsaw, then spent eight years after her PhD in a lab researching the mechanisms of cellular aging and autophagy. She stumbled into science journalism almost by accident — frustrated by how easily her field's findings get oversimplified in the media, she started a blog explaining the biology of aging in plain language. That blog became the seed of VitMode. Today Anna oversees the entire editorial process, holding every piece to the same rigor her old lab demanded: primary sources, methodology checks, and honesty about the limits of the evidence. Outside work, she's a dedicated boulderer.
121 publications on this site
Medical review
dr Piotr ZielińskiEndocrinologist
Piotr has practiced endocrinology for more than fifteen years, mostly in male hormonal disorders and metabolic health. He joined VitMode as a scientific consultant because, as he jokes, he got tired of explaining the same testosterone questions at every appointment and decided to write the answers down properly, once. He reviews content on hormone therapy, supplement pharmacology and drug interactions, making sure articles never turn into encouragement to self-supplement in situations that genuinely need diagnostics and medical supervision. His professional motto — "evidence first, enthusiasm second" — has come up more than once with a patient who arrived with a supplement plan they found online.
174 publications on this site
Related entries
4.2Biological Age Clocks
An umbrella term covering very different methods for estimating the 'true' pace at which an organism is aging — from well-validated second-generation epigenetic clocks to far less proven commercial tests based on glycans or the microbiome. Not all of them carry a comparable level of evidence.
4.1Epigenetic Age Acceleration
The difference between an age estimated from a DNA methylation pattern and chronological age — one of the most statistically well-documented aging biomarkers, strongly linked to mortality in population studies, though still of limited diagnostic value for a single individual.
4.4Telomeres and Telomerase
Protective 'caps' on the ends of chromosomes that shorten with every cell division — one of the most recognizable, though still imperfect, biomarkers of cellular aging.
3.9MicroAge
A machine-learning model that estimates biological age from the composition of the saliva microbiome — a very early, emerging approach to aging biomarkers, distinct from the mortality-focused OMAA Score.
4.1Oral Microbiome Aging
The composition of bacteria colonizing the mouth changes in a predictable way with age — predictable enough that researchers have started building models to estimate biological age from a simple saliva sample.
4.7HbA1c (Glycated Hemoglobin)
A biomarker reflecting average blood glucose over the past 2–3 months — the gold standard for diagnosing and monitoring diabetes, far more stable than a single glucose measurement.
4.1Intrinsic Capacity
A World Health Organization (WHO) concept defining 'true' functional aging as the sum of five domains of physical and mental ability — an alternative to molecular biomarkers, assessed in a clinical exam rather than a lab.
4.0OMAA Score
The OMAA Score (Oral Microbiome Aging Acceleration) is a numerical index calculated as the difference between the age predicted from an oral microbiome sample and a person's actual age — in the study that introduced it, it was linked to elevated mortality and frailty risk.
Related articles
Poradniki5 Biomarkers Worth Knowing Before 40 — Signals Before Symptoms Appear
A standard "once-a-year blood count" often misses early signs of metabolic and hormonal issues. Here are five markers worth asking your doctor about, before anything starts to hurt.
August 1, 2026
PoradnikiCollagen and Skin Health: What Do Two Meta-Analyses Show?
Collagen powder or capsules are one of the fastest-growing segments of the beauty supplement market — and, rare for this category, one of the few where the popular promise ("firmer, better-hydrated skin") has earned solid confirmation in two independent, well-designed meta-analyses. This is a rare situation in supplement science, worth a closer look precisely because the evidence here is unusually consistent.
August 25, 2026
PoradnikiTaurine and Longevity — What Do We Know, and What Don't We Know Yet?
In 2023, the journal Science published a headline-making study: declining taurine levels with age may drive aging, and supplementing it extended lifespan in mice and improved health in monkeys. Headlines quickly turned this into a "fountain of youth," but the study's own authors end their paper by saying that "clinical trials in humans seem warranted." We explain exactly what was shown in animals, what was merely correlated in humans, and why those two things are not the same.
August 25, 2026
PoradnikiDHEA After 40: Does Supplementing the "Youth Hormone" Make Sense?
DHEA (dehydroepiandrosterone) is a hormone produced by the adrenal glands whose level steadily declines from around age 25 — by age 70 it can be as much as 80% lower than in youth. This decline has made DHEA one of the most commonly supplemented "youth hormones" in the United States, where it's sold over the counter. But the largest, two-year randomized trial, published in the New England Journal of Medicine, found no evidence that supplementation restores muscle strength, improves body composition, or improves insulin sensitivity in aging men and women. We check where the evidence actually ends and the marketing begins.
September 4, 2026
Comments (2)
- KW
Kasia W. 2 weeks ago
Very clearly explained, especially the interactions section — I hadn't seen it laid out this well anywhere else.
- MT
Marek T. a month ago
Are you planning to update this with the newest study from this year? I saw an interesting meta-analysis.